Kinnate Biopharma(KNTE) - 2021 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) (Exact name of Registrant as specified in its Charter) Delaware 82-4566526 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 103 Montgomery Street, Suite 150 The Presidio of San Francisco San Francisco, CA 94129 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (858) 299-4699 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 ...